相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 PD-1/CD279 抗体 (斯巴达珠单抗 / 斯普拜奇单抗),生物类似药,科研用途 [ CAS: 1935694-88-4]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Humanized
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
PD-1/CD279
- 抗体名:
PD-1/CD279
- 规格:
1mg
BioSIM 抗人 PD-1/CD279 抗体 (斯巴达珠单抗生物类似物)
产品概述
BioSIM anti-Human PD-1/CD279 Antibody (Spartalizumab Biosimilar) 是一种高特异性的人源化抗体,专为科研用途设计。作为斯巴达珠单抗的生物类似物,该产品在无动物成分的设施中生产,采用先进的体外无蛋白细胞培养技术,并通过多步骤纯化工艺确保产品纯度。
产品规格
- 产品名称:BioSIM 抗人 PD-1/CD279 抗体 (斯巴达珠单抗 / 斯普拜奇单抗)
- 货号:SIM0445-1mg
- 规格:1mg
- CAS号:1935694-88-4
- 供应商:InvivoCrown
- 产品类型:二抗
产品特性
- 来源宿主:Humanized(人源化)
- 反应性:Human(人源)
- 研究领域:骨髓增生异常综合征,慢性骨髓单核细胞性白血病,鳞状细胞癌
- 应用类型:ELISA, FACS, Functional assay, Research in vivo
生产与纯化
该重组生物类似抗体是在严格控制的无动物成分设施中生产的,仅使用体外的无蛋白细胞培养技术,确保了产品的纯净度和一致性。经过多步骤的纯化过程,其中包括采用Protein A或G的色谱工艺,可高特异性地识别并结合人源PD-1/CD279蛋白。
应用领域
本抗体适用于多种免疫学研究应用:
- ELISA实验:用于检测样本中PD-1/CD279蛋白的表达水平
- FACS分析:可用于流式细胞术检测细胞表面PD-1/CD279的表达
- 功能性实验:评估PD-1/CD279信号通路在免疫调节中的作用
- 体内研究:在动物模型中研究PD-1/CD279介导的免疫应答
储存条件
为确保抗体活性和稳定性,请遵循以下储存建议:
- 避免反复冻融,以保持抗体活性
- 短期储存(1-2周):4°C
- 中期储存(最长12个月):-20°C
- 长期储存:-80°C
注意事项
本产品仅限科研使用,不可用于临床诊断或治疗。关于该抗体的免疫原性信息,请参考产品说明书。在使用前,建议进行小样测试以确定最佳实验条件。
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM Anti-Human PD-1/CD279 Antibody (Spartalizumab Biosimilar)
Product Overview
BioSIM anti-Human PD-1/CD279 Antibody (Spartalizumab Biosimilar) is a highly specific humanized antibody designed for research purposes. As a biosimilar of Spartalizumab, this product is produced in an animal component-free facility using advanced animal-free cell culture technology in vitro, and its purity is ensured through a multi-step purification process.
Product Specifications
- Product Name: BioSIM Anti-Human PD-1/CD279 Antibody (Spartalizumab / SpartaCrest)
- Catalog Number: SIM0445-1mg
- Specification: 1mg
- CAS Number: 1935694-88-4
- Supplier: InvivoCrown
- Product Type: Secondary Antibody
Product Characteristics
- Host Origin: Humanized
- Reactivity: Human
- Research Areas: Myelodysplastic syndromes, Chronic myelomonocytic leukemia, Squamous cell carcinoma
- Application Types: ELISA, FACS, Functional assay, Research in vivo
Production and Purification
This recombinant biosimilar antibody is produced under strict control in an animal component-free facility, using only animal-free cell culture technology in vitro, ensuring product purity and consistency. Through a multi-step purification process, including chromatography with Protein A or G, it can specifically recognize and bind to human PD-1/CD279 protein.
Application Areas
This antibody is suitable for various immunological research applications:
- ELISA: Used to detect the expression level of PD-1/CD279 protein in samples
- FACS Analysis: Can be used for flow cytometry to detect the expression of PD-1/CD279 on the cell surface
- Functional Assays: To evaluate the role of PD-1/CD279 signaling pathway in immune regulation
- In Vivo Research: To study PD-1/CD279-mediated immune responses in animal models
Storage Conditions
To ensure antibody activity and stability, please follow the storage recommendations below:
- Avoid repeated freeze-thaw cycles to maintain antibody activity
- Short-term storage (1-2 weeks): 4°C
- Medium-term storage (up to 12 months): -20°C
- Long-term storage: -80°C
Precautions
This product is for research use only and is not intended for diagnostic or therapeutic purposes. For information on the immunogenicity of this antibody, please refer to the product manual. Before use, it is recommended to perform a small-scale test to determine optimal experimental conditions.
Note: The above information may change due to factors such as product optimization and upgrades. Please consult Yacoen Company for specific information.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料






